The octahedral ionic Ir(III) complex with a dual stereogenic centre of general formula Δ,Λ-(R,S)-[(ppy)₂Ir(Me-Campy)]X, where ppy = 2-phenylpyridine and Me-Campy = 2-methyl-5,6,7,8-tetrahydroquinolin-8-amine, and the complex Λ-(R,S)-[(ppy)₂Ir(H-Campy)]X, where ppy = 2-phenylpyridine, H-Campy = 8-amino-5,6,7,8-tetrahydroquinolines and X⁻ = Cl⁻ as a counterion in both cases, have been characterized by vibrational circular dichroism (VCD), which turns out to be efficacious in diastereomeric discrimination. Moreover, the single crystal X-ray structure of the complex Δ-(R)-[(ppy)₂Ir(Me-Campy)]Cl is reported here. Density functional theory (DFT) calculations allow us to conclude that the most important doublet feature in the VCD spectra is associated with a clear vibrational exciton structure located on the two dissymmetrically disposed phenylpyridine ligands. The features in the VCD spectra associated with the (R) or (S)-central chirality configuration are identified and commented on. DFT calculations provide also the interpretation of electronic circular dichroism (ECD) spectra. Finally, circularly polarized luminescence (CPL) spectra are presented as an additional chiroptical characterization of these luminescent iridium complexes.

A library of monosubstituted chalcones (1–17) bearing electron-donating and electron-withdrawing groups on both aromatic rings were selected. The cell viability on human tumor cell lines was evaluated first. The compounds unable to induce detectable cytotoxicity (1, 13, and 14) were tested using the monoamine oxidase (MAO) activity assay. Interestingly, they inhibit MAO-B, acting as competitive inhibitors, with 13 and 14 showing the best profiles. In particular, 13 exhibited a potency higher than that of safinamide, taken as a reference. Docking studies and crystallographic analysis showed that in human MAO-B 13 binds with the halogen-substituted aromatic ring in the entrance cavity, similar to safinamide, whereas 14 is accommodated in the opposite way. The main conclusion of this cell biology, biochemistry, and structural study is to highlights 13 as a chalcone derivative that is worth consideration for the development of novel MAO-B-selective inhibitors for the treatment of neurodegenerative diseases.